|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
33.550 +1.150 (+3.549%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 931,290 | 1,133,551 | 1,162,719 | 892,374 |
| Net Cash from / (used in) Investing Activities | -- | (1,315,076) | (2,565,410) | (2,521,608) | (2,231,312) |
| Net Cash from / (used in) Financing Activities | -- | (7,807) | 809,249 | (163,093) | 9,339,458 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (391,593) | (622,610) | (1,521,982) | 8,000,520 |
| Cash & Cash Equivalents at beginning of period | -- | 7,782,741 | 8,378,417 | 9,959,963 | 2,006,926 |
| Effect of Foreign Exchange Rate Changes | -- | 8,793 | 26,934 | (59,564) | (47,483) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 7,399,941 | 7,782,741 | 8,378,417 | 9,959,963 |
| Remarks: | Real time quote last updated: 27/11/2024 12:02 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 492,849 |
| %Change | -64.501% |
| EPS / (LPS) | RMB 0.570 |
| NBV Per Share (¥) | RMB 24.007 |